Tag Archives: pharma

US Sells “Priceless” Album Seized From Pharma Douche

CNBC reports: A one-of-a-kind album by the hip-hop group Wu-Tang Clan that was once owned by notorious “Pharma Bro” Martin Shkreli finally has been sold by the U.S. government, three years after Shkreli forfeited the record as part of his conviction for securities fraud. The buyer and the sale price of the album, “Once Upon a Time in Shaolin,” were …

Read More »

Pfizer To Pay $345 Million In EpiPen Anti-Trust Lawsuit

Reuters reports: Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anti-competitive and unfair practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan. The proposed class action settlement was disclosed in a filing in federal court in Kansas City, Kansas. The deal, which …

Read More »

Major Hospitals Won’t Carry New Alzheimer’s Med

Reuters reports: The rollout of Biogen Inc’s Alzheimer’s drug is hitting new roadblocks as some large hospitals decide not to use it and many health insurers await coverage terms from Medicare, the U.S. health plan for people aged 65 and older, before setting their own policies. Cleveland Clinic, one of the country’s best-known health systems, and New York’s Mount Sinai …

Read More »

FDA Limits Usage Of New Alzheimer’s Medication

The Washington Post reports: The Food and Drug Administration on Thursday limited the recommended use of a controversial new Alzheimer’s drug to patients with mild cognitive impairment or early dementia from the disease — a major change from the original label that included everyone with the illness. The revised label clarifies that the drug, called Aduhelm, is intended for patients …

Read More »

Pfizer To Seek US Approval For Third Vaccine Dose

NBC News reports: Pfizer is about to seek U.S. authorization for a third dose of its Covid-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant. Research from multiple countries shows the Pfizer shot and other widely used Covid-19 vaccines offer strong protection against the highly …

Read More »

STUDY: Novavax Jab 90% Effective Against Variants

The Wall Street Journal reports: An experimental Covid-19 vaccine from Novavax was 90.4% effective at preventing symptomatic disease in adults in a large clinical trial, the company said, results that move the shot a step closer to global use. The 29,960-person study conducted in the U.S. and Mexico also found that the vaccine was similarly effective against newer coronavirus strains, …

Read More »

CEO Defends $56K Annual Cost Of Alzheimer’s Med

CNBC reports: Biogen CEO Michel Vounatsos told CNBC on Monday that the list price of $56,000 per year for the company’s FDA-approved Alzheimer’s disease drug aducanumab is “fair.” That being said, the Massachusetts-based biotech company has vowed to not increase the price of the medication, which is marketed under the name Aduhelm, for the next four years, Vounatsos said. The …

Read More »

FDA Approves Biogen’s New Alzheimer’s Medication

CNBC reports: The Food and Drug Administration on Monday approved Biogen Alzheimer’s drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer’s and the first new medicine for the disease in nearly two decades. The FDA’s decision was highly anticipated. The drug, which is marketed under the name Aduhelm, is …

Read More »

FDA To Rule Tomorrow On New Alzheimer’s Medication

The New York Times reports: The Food and Drug Administration is on the verge of announcing one of its most contentious decisions in years: the fate of an Alzheimer’s drug that could be the first treatment approved after nearly two decades of failed efforts to find ways to curb the debilitating disease. On Monday, the agency will rule on the …

Read More »

Moderna Reports Vaccine Is 100% Effective In Teens

CNBC reports: Moderna said Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer’s to demonstrate high efficacy in younger age groups. The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next …

Read More »

COVID Vax Boosters May Be Needed By September

Axios reports: The first Americans to be vaccinated against the coronavirus could require a third “booster” shot as early as September, the CEOs of Pfizer and Moderna told Axios. “The data that I see coming, they are supporting the notion that likely there will be a need for a booster somewhere between eight and 12 months,” Pfizer CEO Albert Bourla …

Read More »

Feds Accuse Pharma Douche Of Destroying Evidence

Law & Crime reports: The Federal Trade Commission accused disgraced pharmaceutical executive Martin Shkreli on Tuesday of having destroyed evidence relevant to a lawsuit that could lead to his lifetime ban from the industry. Regulators claim that the convicted fraudster invoked his Fifth Amendment right against self-incrimination when asked about a phone he used to conduct business from prison. “It …

Read More »

FDA Approves Pfizer Vaccine For Kids Ages 12 To 15

CNBC reports: The Food and Drug Administration approved Pfizer and BioNTech’s request to allow their Covid-19 vaccine to be given to kids ages 12 to 15 on an emergency use basis, allowing states to get middle school students vaccinated before the fall. The U.S. agency granting use of the shot in adolescents will also accelerate the nation’s efforts to drive …

Read More »

Breaking: US Backs Patent Waivers For COVID Vaccines

CNBC reports: The Biden administration announced Wednesday that it supports waiving intellectual property protections for Covid-19 vaccines, as countries struggle to manufacture the life-saving doses. “This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures. The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the …

Read More »

White House: No Decision Yet On Vax Patent Waivers

The Hill reports: President Biden has not made a decision yet on whether to support a waiver of COVID-19 vaccine patents that backers say would help increase global access to vaccines, White House press secretary Jen Psaki said Tuesday. “Our focus is on maximizing production and supply for the world at the lowest possible cost and there are a lot …

Read More »

Pfizer CEO: COVID Preventive Could Be Ready In 2022

Axios reports: An oral antiviral drug to stop the virus that causes COVID-19 from replicating could be ready next year “if all goes right,” Pfizer CEO Albert Bourla told CNBC on Tuesday, adding that the drug should work against all variants of the virus. Why it matters: Antiviral drugs can be a key pandemic-fighting tool, since not everyone will get …

Read More »

CDC Panel Recommends Lifting Pause On J&J Vaccine

Courthouse News reports: An independent advisory panel for the U.S. Centers for Disease Control and Prevention voted Friday to recommend the continued use of the Johnson & Johnson Covid-19 vaccine after the single-dose jab was put on pause over blood clotting concerns. Friday’s vote followed similar concerns in the Europe Union over both the J&J jab and the AstraZeneca vaccine, …

Read More »

Pfizer: Fake Vaccines Are Selling In Mexico And Poland

The Wall Street Journal reports: Pfizer Inc. says it has identified in Mexico and Poland the first confirmed instances of counterfeit versions of the Covid-19 vaccine it developed with BioNTech SE , the latest attempt by criminals trying to exploit the world-wide vaccination campaign. Vials seized by authorities in separate investigations were tested by the company and confirmed to contain …

Read More »

Adults In All 50 States Now Eligible For COVID Vaccine

Axios reports: All 50 U.S. states, plus Washington, D.C. and Puerto Rico, have now made U.S. adults over the age of 16 eligible for COVID-19 vaccines, meeting President Biden’s April 19 deadline. The landmark speaks to the increased pace of the national vaccination campaign, but will increase pressure on the federal government, states and pharmaceutical companies to provide adequate vaccine …

Read More »

Moderna To Have Third Booster Shot Available By Fall

CBS News reports: COVID-19 vaccine maker Moderna will make a third booster shot for its two-dose vaccine available to Americans by the fall, CEO Stéphane Bancel said this week. Moderna’s vaccine is more than 90% effective against the coronavirus six months after the second shot, studies show. What remains unclear is how long immunity from the virus lasts. The same …

Read More »